Location History:
- Frankfurt-am-Main, DE (2006 - 2008)
- Grebenau, DE (2007 - 2011)
- Bonn, DE (2012 - 2014)
Company Filing History:
9 out of 1,829 
2 out of 30 Years Active: 2006-2014
Title: Evi Kostenis: Innovator in GPR17 Research
Introduction
Evi Kostenis is a prominent inventor based in Grebenau, Germany. She has made significant contributions to the field of biological research, particularly in the study of GPR17, a G protein-coupled receptor. With a total of 11 patents to her name, Kostenis has established herself as a leading figure in her area of expertise.
Latest Patents
Among her latest patents, Kostenis has developed methods related to GPR17 agonists and screening assays. The first patent focuses on a method for determining a test compound's ability to modify the biological activity of GPR17. This method involves contacting the test compound with GPR17 or a functional GPR17 fragment in the presence of a suitable amount of a GPR17 agonist of a specific formula. Another patent outlines methods for identifying modulators of GPR17, emphasizing the same fundamental approach of testing compounds for their effects on this receptor.
Career Highlights
Throughout her career, Evi Kostenis has worked with notable organizations, including Sanofi-Aventis Deutschland GmbH and Rheinische Friedrich-Wilhelms-Universität Bonn. Her work in these institutions has allowed her to advance her research and collaborate with other experts in the field.
Collaborations
Some of her notable coworkers include Johann Gassenhuber and Detlef Kozian. Their collaborative efforts have contributed to the advancement of research in GPR17 and related areas.
Conclusion
Evi Kostenis is a distinguished inventor whose work in GPR17 research has led to significant advancements in the field. Her numerous patents and collaborations highlight her dedication to innovation and scientific discovery.